Spironolactone Tablet
Product Images NDC 68071-2989

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68071-2989). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2989 9)

This is medication information for Spironolactone 25mg tablets, with a lot number of 00000 and NDC number of 68071-2989-09. The tablets are manufactured by MFR and have an expiration date of 00-00. The tablets contain Spironolactone USP 25mg and are RX only. The package comes with 90 tablets, with each tablet debossed on one side and "Sedal" and a serial number of 0000000002 on the other side. The product should be stored at a temperature of 68-77°F and kept out of reach of children. It warns users to call a doctor for medical advice about side effects and that side effects can be reported to the FDA at 1-800-FDA-1088.*

FDA Label Image

Figure (Spironolactone Fig1)

This appears to be a statistical analysis of a clinical trial comparing the effects of Spironolactone and a Placebo on a group of n=822 and n=841 participants respectively, over a period of 18 months. The log-rank p value is reported to be less than 0.0001, indicating a significant difference between the two groups. The remaining text (Probabilty, 02, 01, 00, B, T, a8) are not clear and do not provide any additional information.*

FDA Label Image

Fig2 (Spironolactone Fig2)

This appears to be a table with various parameters related to a medical subgroup study. The parameters include Age, Race, LVEF (%), HeartFaiure, NYHA, Diabetes, SerCreatiine (mo/dL), Cr Clearence (mUmin/t 73 5 m), Pofassium (mmol), Digoxin, acel, Beta Blocker, Level, and HR and 95% CI. The table also includes values and subgroups for these parameters. The study compares the efficacy of Spironolactone versus Placebo.*

FDA Label Image

Str1 (Spironolactone Str1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.